Ca2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation

Journal of Neuroscience

Volumn 27, Issue 30, 2007, Pages 7987-8001

  Ishiuchi, Shogo ^a   Yoshida, Yukari ^a   Sugawara, Kenichi ^a   Aihara, Masanori ^a   Ohtani, Toshiyuki ^a   Watanabe, Takashi ^a   Saito, Nobuhito ^a   Tsuzuki, Keisuke ^a   Okado, Haruo ^b   Miwa, Akiko ^b   Nakazato, Yoichi ^a   Ozawa, Seiji ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Akt; AMPA receptors; Brain tumor; Calcium signaling; Glioblastoma; Invasion

Indexed keywords

AMPA RECEPTOR; CALCIUM ION; COMPLEMENTARY DNA; GLUTAMATE RECEPTOR 2; PROTEIN KINASE B; CALCIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CANCER GROWTH; CANCER INVASION; CELL GROWTH; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TUMOR CELL; ANIMAL; BRAIN TUMOR; CELL CULTURE; COMPARATIVE STUDY; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; PERMEABILITY; PHYSIOLOGY; RAT;

ANIMALS; BRAIN NEOPLASMS; CALCIUM; CALCIUM SIGNALING; CELL PROLIFERATION; GLIOBLASTOMA; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; PERMEABILITY; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTORS, AMPA; TUMOR CELLS, CULTURED;

EID: 34547438107     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2180-07.2007     Document Type: Article

References (64)

1. Alessi DR, Cohen P (1998) Mechanism of activation and function of protein kinase B. Curr Opin Genet Dev 8:55-62.
2. Bailey P, Cushing H (1926) A classification of tumors of the glioma group on a histogenetic basis with a correlation study of prognosis. Philadelphia: Lippincott.
3. Bochet P, Audinat E, Lambolez B, Crépel F, Rossier J, Iino M, Tsuzuki K, Ozawa S (1994) Subunit composition at the single-cell level explains functional properties of a glutamate-gated channel. Neuron 12:383-388.
4. Burnashev N, Monyer H, Seeburg PH, Sakmann B (1992) Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 8:189-198.
5. Cantley LC, Neel BG (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96:4240-4245.
6. Choe G, Horvath S, Cloughesy TF, Crosby K, Seligson D, Palotie A, Inge L, Smith BL, Sawyers CL, Mischel PS (2003) Analysis of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res 63:2742-2746.
7. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241.
8. Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: a play in three Akts. Genes Dev 13:2905-2927.
9. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP (1998) Pten is essential for embryonic development and tumour suppression. Nat Genet 19:348-355.
10. Feng J, Park J, Cron P, Hess D, Hemmings BA (2004) Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J Biol Chem 279:41189-41196.
11. Filippa N, Sable CL, Filloux C, Hemmings BA, Van Obberghen E (1999) Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase. Mol Cell Biol 19:4989-5000.
12. Gao T, Furnari F, Newton AC (2005) PHLPP: a phosphatase that dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 18:13-24.
13. 2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron 15:193-204.
14. Guha A, Feldkamp MM, Lau N, Boss G, Pawson A (1997) Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene 15:2755-2765.
15. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25:55-57.
16. Hollmann M, Heinemann S (1994) Cloned glutamate receptors. Annu Rev Neurosci 17:31-108.
17. 2+-permeable AMPA receptors in Bergmann glia. Science 292:926-929.
18. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vöckler J, Dikranian K, Tenkova T, Stefovska V, Turski L, Olneny JW (1999) Blokade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283:70-74.
19. Ishiuchi S, Nakazato Y, Iino M, Ozawa S, Tamura M, Ohye C (1998) In vitro neuronal and glial production and differentiation of human central neurocytoma cells. J Neurosci Res 51:526-535.
20. 2+-permeable AMPA receptor channels. NeuroReport 12:745-748.
21. 2+-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med 8:971-978.
22. Kanegae Y, Takamori K, Sato Y, Lee G, Nakai M, Saito I (1996) Efficient gene activation system on mammalian cell chromosomes using recombinant adenovirus producing Cre recombinase. Gene 181:207-212.
23. Kim D, Kim S, Koh H, Yoon SO, Chung AS, Cho KS, Chung J (2001) Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J 15:1953-1962.
24. Kitamura T, Ogawa W, Sakaue H, Hino Y, Kuroda S, Takata M, Matsumoto M, Maeda T, Konishi H, Kikkawa U, Ogawa W, Kasuga M (1998) Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol Cell Biol 18:3708-3717.
25. Kleihues P, Burger PC, Collins VP, Newcombb EW, Ohgaki H, and Cavenee WK (2000) Glioblastoma. In: World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system (Kleihues P, Cavenee WK, eds), pp 29-39. Lyon, France: ARC.
26. Kohara A, Okada M, Tsutsumi R, Ohno K, Takahashi M, Shimizu-Sasamata M, Shishikura J, Inami H, Sakamoto S, Yamaguchi T (1998) In vitro characterization of YM872, a selective, potent and highly water-soluble α-amino-3-hydroxy- 5-methylisoxazole-4-propionate receptor antagonist. J Pharm Pharmacol 50:795-801.
27. Kohn AD, Takeuchi F, Roth RA (1996a) Akt, apleckstrin homology domain containing kinase is activated primarily by phosphorylation. J Biol Chem 271:21920-21926.
28. 2+ determine nerve growth factor dependence of sympathetic ganglion cells. Proc Natl Acad Sci USA 86:6421-6425.
29. Labrakakis C, Patt S, Hartmann J, Kettenmann H (1998) Glutamate receptor activation can trigger electrical activity in human glioma cells. Eur J Neurosci 10:2153-2162.
30. Lefranc F, Britchi J, Kiss R (2005) Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23:2411-2422.
31. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Want SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bignaer SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wiqler MH, Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947.
32. Lokker NA, Sullivan CM, Hollenbach SJ, Israel MA, Giese NA (2002) Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res 62:3729-3735.
33. Maas S, Patt S, Schrey M, Rich A (2001) Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc Natl Acad Sci USA 98:14687-14692.
34. Maehama T, Dixon JE (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:13375-13378.
35. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev 15:1311-1333.
36. Maira SM, Galetic I, Brazil DP, Kaech S, Ingley E, Thelen M, and Hemmings BA (2001) Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane. Science 294:374-380.
37. McCarthy KD, de Vellis (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
38. Mellinghoff IK, Wang MD, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ, Lu KV, Yoshimoto K, Huang JHY, Chute DJ, Riggs BL, Horvath S, Liau LM, Cavenee WK, Rao PN, Beroukhim R, Peck TC, Lee JC, Sellers WR, Stokoe D, et al. (2005) Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 353:2012-2024.
39. Mitchison TJ, Cramer LP (1996) Actin-based cell motility and cell locomotion. Cell 84:371-379.
40. Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, Saito I (1996) Efficient generation of recombinant adenoviruses using DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 93:1320-1324.
41. Namikawa K, Honma M, Abe K, Takeda M, Mansur K, Obata T, Miwa A, Okado H, Kiyama H (2000) Akt/protein kinase B prevents injuryinduced motoneuron death and accelerates axonal regeneration. J Neurosci 20:2875-2886.
42. Osaki M, Oshimura M, Ito H (2004) PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9:667-676.
43. Ozawa S, Kamiya H, Tsuzuki K (1998) Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 54:581-618.
44. Resh MD (1994) Myristylation and palmitylation of Src family members: the fasts of the matter. Cell 76:411-413.
45. Rzeski W, Turski L, Ikonomidou C (2001) Glutamate antagonists limit tumor growth. Proc Natl Acad Sci USA 98:6372-6377.
46. Sable CL, Filippa N, Hemmings B, Van Obberghen E (1997) cAMP stimulates protein kinase B in a wortmannin-insensitive manner. FEBS Lett 409:253-257.
47. Sakurai T, Okada Y (1992) Selective reduction of glutamate in the rat superior colliculus and dorsal lateral geniculate nucleus after contralateral enucleation. Brain Res 573:197-203.
48. Sanai N, Alvarez-Buylla A, Berger MS (2005) Neural stem cells and origin of gliomas. N Engl J Med 353:811-822.
49. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt/PKB by Rictor-mTOR complex. Science 307:1098-1101.
50. Sasaki A, Tamura M, Hasegawa M, Ishiuchi S, Hirato J, Nakazato Y (1998) Expression of interleukin-1beta mRNA and protein in human gliomas assessed by RT-PCR and immunohistochemistry. J Neuropathol Exp Neurol 57:653- 663.
51. Sasaki A, Ishiuchi S, Kanda T, Hasegawa M, and Nakazato Y (2001) Analysis of interleukin-6 gene expression in primary human gliomas, glioblastoma xenografts and glioblastoma cell lines. Brain Tumor Pathol 18:13-21. Seeburg PH (1993) The molecular biology of mammalian glutamate receptor channels. Trends Neurosci 16:359-365.
52. Shawver LK, Salmon D, Ullrich HM (2002) Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 1:117-123.
53. Smith JS, Tachibana I, Passe SM, Huntley BK, Borell TJ, Iturria N, O'Fallon JR, Schaefer PL, Scheithauer BW, James CD, Buckner JC, Jenkins RB (2001) PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst 93:1246-1256.
54. Sontheimer H (2003) Malignant gliomas: perverting glutamate and ion homeostasis for selective advantage. Trends Neurosci 26:543-549.
55. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29-39.
56. Takano T, Lin JH, Arcuino G, Gao Q, Yang J, Nedergaard M (2001) Glutamate release promotes growth of malignant gliomas. Nat Med 7:1010-1015.
57. Takata M, Ogawa W, Kitamura T, Hino Y, Kuroda S, Kotani K, Klip A, Gingras AC, Sonenberg N, Kasuga M (1999) Requirement for Akt (protein kinase B) in insulin-induced activation of glycogen synthase and phosphorylation of 4E-BP1 (PHAS-1). J Biol Chem 274:20611-20618.
58. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM (1998) Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280:1614-1617.
59. Toker A, Newton AC (2000) Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J Biol Chem 275:8271-8274.
60. Vanhaesebroeck B, Alessi DR (2000) The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346:561-576.
61. Williams MR, Arthur JS, Balendran A, van der Kaay J, Poli V, Choen P, and Alessi DR (2000) The role of 3-phoshoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr Biol 10:439-448.
62. Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL (1998) The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci USA 95:15587-15591.
63. Yano S, Tokumitsu H, Soderling TR (1998) Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature 396:584-587.
64. Yoshida Y, Tsuzuki K, Ishiuchi S, Ozawa S (2006) Serum-dependence AMPA receptor mediated proliferation in glioma cells. Pathol Int 56:262-271.